CTRI/2018/08/015462已完成4 期
Post marketing surveillance program of PraxbindTM use inIndia
Boehringer Ingelheim India Private Ltd0 个研究点目标入组 5 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Patients treated with Pradaxa (dabigatran etexilate)
- •capsules with requirement of rapid reversal of the
- •anticoagulant effects of dabigatran:
- •ï?· For emergency surgery/urgent procedures
- •ï?· In life-threatening or uncontrolled bleeding
- •2. Written informed consent in accordance with
- •International Conference on Harmonization Good
- •Clinical Practice (GCP) guidelines and local legislation
- •and/or regulations.
排除标准
- •Participation in a PraxbindTM clinical trial
研究者
相似试验
进行中（未招募）
不适用
reactogenicity and safety of Vaxem™HibMeningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b.EUCTR2014-005203-24-Outside-EU/EEAovartis Vaccines and Diagnostics750
招募中
4 期
A post marketing study to evaluate safety and effectiveness of Remogliflozin and Remogliflozin-Metformin Combination in treatment of Diabetes patientsCTRI/2019/11/022062Glenmark Pharmaceuticals Ltd
进行中（未招募）
4 期
To collect safety data in patients with Wet-AMD after giving aflibercept injection in affected eye.CTRI/2017/12/010876Bayer Pharmaceutical Pvt Ltd
已完成
4 期
This is an observational study to determine the efficacy and safety of vitamin-c in facial photodamageCTRI/2010/091/001161Cipla Ltd24
招募中
4 期
Post Marketing Surveillance Study (PMS) to generate safety and efficacy data of Febrex Plus SyrupCTRI/2020/06/025925Indoco Remedies Limited